Medical Care
Global Insomnia Therapeutics Drugs Market Research Report 2024
- Jan 20, 24
- ID: 15938
- Pages: 85
- Figures: 166
- Views: 35
The global Insomnia Therapeutics Drugs market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapeutics Drugs.
Report Scope
The Insomnia Therapeutics Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Segment by Type
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Segment by Application
Prescription
Over-the-Counter (OTC)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Therapeutics Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insomnia Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapeutics Drugs.
Report Scope
The Insomnia Therapeutics Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insomnia Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insomnia Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Segment by Type
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Segment by Application
Prescription
Over-the-Counter (OTC)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Insomnia Therapeutics Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Benzodiazepines
1.2.3 Nonbenzodiazepines
1.2.4 Antidepressants
1.2.5 Orexin Antagonists
1.2.6 Melatonin Antagonists
1.2.7 Others
1.3 Market by Application
1.3.1 Global Insomnia Therapeutics Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapeutics Drugs Market Perspective (2019-2030)
2.2 Insomnia Therapeutics Drugs Growth Trends by Region
2.2.1 Global Insomnia Therapeutics Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Insomnia Therapeutics Drugs Historic Market Size by Region (2019-2024)
2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Region (2025-2030)
2.3 Insomnia Therapeutics Drugs Market Dynamics
2.3.1 Insomnia Therapeutics Drugs Industry Trends
2.3.2 Insomnia Therapeutics Drugs Market Drivers
2.3.3 Insomnia Therapeutics Drugs Market Challenges
2.3.4 Insomnia Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapeutics Drugs Players by Revenue
3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2019-2024)
3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapeutics Drugs Revenue
3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2023
3.5 Insomnia Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Insomnia Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Insomnia Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapeutics Drugs Breakdown Data by Type
4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2019-2024)
4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2025-2030)
5 Insomnia Therapeutics Drugs Breakdown Data by Application
5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2019-2024)
5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Insomnia Therapeutics Drugs Market Size (2019-2030)
6.2 North America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
6.4 North America Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Therapeutics Drugs Market Size (2019-2030)
7.2 Europe Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
7.4 Europe Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size (2019-2030)
8.2 Asia-Pacific Insomnia Therapeutics Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Therapeutics Drugs Market Size (2019-2030)
9.2 Latin America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
9.4 Latin America Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size (2019-2030)
10.2 Middle East & Africa Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company Ltd.
11.1.1 Takeda Pharmaceutical Company Ltd. Company Detail
11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
11.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.1.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.2 Vanda Pharmaceuticals
11.2.1 Vanda Pharmaceuticals Company Detail
11.2.2 Vanda Pharmaceuticals Business Overview
11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
11.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.2.5 Vanda Pharmaceuticals Recent Development
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Detail
11.3.2 Merck & Co., Inc. Business Overview
11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
11.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.3.5 Merck & Co., Inc. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.4.5 Pfizer Inc. Recent Development
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Detail
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
11.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.6.5 Mylan N.V. Recent Development
11.7 Sumitomo Dainippon Pharma Co., Ltd
11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail
11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
11.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Paratek Pharmaceuticals Inc.
11.9.1 Paratek Pharmaceuticals Inc. Company Detail
11.9.2 Paratek Pharmaceuticals Inc. Business Overview
11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
11.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.9.5 Paratek Pharmaceuticals Inc. Recent Development
11.10 Ebb Therapeutics
11.10.1 Ebb Therapeutics Company Detail
11.10.2 Ebb Therapeutics Business Overview
11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
11.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.10.5 Ebb Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Benzodiazepines
1.2.3 Nonbenzodiazepines
1.2.4 Antidepressants
1.2.5 Orexin Antagonists
1.2.6 Melatonin Antagonists
1.2.7 Others
1.3 Market by Application
1.3.1 Global Insomnia Therapeutics Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapeutics Drugs Market Perspective (2019-2030)
2.2 Insomnia Therapeutics Drugs Growth Trends by Region
2.2.1 Global Insomnia Therapeutics Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Insomnia Therapeutics Drugs Historic Market Size by Region (2019-2024)
2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Region (2025-2030)
2.3 Insomnia Therapeutics Drugs Market Dynamics
2.3.1 Insomnia Therapeutics Drugs Industry Trends
2.3.2 Insomnia Therapeutics Drugs Market Drivers
2.3.3 Insomnia Therapeutics Drugs Market Challenges
2.3.4 Insomnia Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Insomnia Therapeutics Drugs Players by Revenue
3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2019-2024)
3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Insomnia Therapeutics Drugs Revenue
3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2023
3.5 Insomnia Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Insomnia Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Insomnia Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapeutics Drugs Breakdown Data by Type
4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2019-2024)
4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2025-2030)
5 Insomnia Therapeutics Drugs Breakdown Data by Application
5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2019-2024)
5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Insomnia Therapeutics Drugs Market Size (2019-2030)
6.2 North America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
6.4 North America Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Insomnia Therapeutics Drugs Market Size (2019-2030)
7.2 Europe Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
7.4 Europe Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size (2019-2030)
8.2 Asia-Pacific Insomnia Therapeutics Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Insomnia Therapeutics Drugs Market Size (2019-2030)
9.2 Latin America Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
9.4 Latin America Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size (2019-2030)
10.2 Middle East & Africa Insomnia Therapeutics Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company Ltd.
11.1.1 Takeda Pharmaceutical Company Ltd. Company Detail
11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
11.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.1.5 Takeda Pharmaceutical Company Ltd. Recent Development
11.2 Vanda Pharmaceuticals
11.2.1 Vanda Pharmaceuticals Company Detail
11.2.2 Vanda Pharmaceuticals Business Overview
11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
11.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.2.5 Vanda Pharmaceuticals Recent Development
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Detail
11.3.2 Merck & Co., Inc. Business Overview
11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
11.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.3.5 Merck & Co., Inc. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.4.5 Pfizer Inc. Recent Development
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Detail
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
11.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.6.5 Mylan N.V. Recent Development
11.7 Sumitomo Dainippon Pharma Co., Ltd
11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Detail
11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
11.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Paratek Pharmaceuticals Inc.
11.9.1 Paratek Pharmaceuticals Inc. Company Detail
11.9.2 Paratek Pharmaceuticals Inc. Business Overview
11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
11.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.9.5 Paratek Pharmaceuticals Inc. Recent Development
11.10 Ebb Therapeutics
11.10.1 Ebb Therapeutics Company Detail
11.10.2 Ebb Therapeutics Business Overview
11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
11.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2019-2024)
11.10.5 Ebb Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Benzodiazepines
Table 3. Key Players of Nonbenzodiazepines
Table 4. Key Players of Antidepressants
Table 5. Key Players of Orexin Antagonists
Table 6. Key Players of Melatonin Antagonists
Table 7. Key Players of Others
Table 8. Global Insomnia Therapeutics Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Insomnia Therapeutics Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Insomnia Therapeutics Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Insomnia Therapeutics Drugs Market Share by Region (2019-2024)
Table 12. Global Insomnia Therapeutics Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Insomnia Therapeutics Drugs Market Share by Region (2025-2030)
Table 14. Insomnia Therapeutics Drugs Market Trends
Table 15. Insomnia Therapeutics Drugs Market Drivers
Table 16. Insomnia Therapeutics Drugs Market Challenges
Table 17. Insomnia Therapeutics Drugs Market Restraints
Table 18. Global Insomnia Therapeutics Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Insomnia Therapeutics Drugs Market Share by Players (2019-2024)
Table 20. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2023)
Table 21. Ranking of Global Top Insomnia Therapeutics Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Insomnia Therapeutics Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Insomnia Therapeutics Drugs Product Solution and Service
Table 25. Date of Enter into Insomnia Therapeutics Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Insomnia Therapeutics Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Insomnia Therapeutics Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Insomnia Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Insomnia Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Insomnia Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Insomnia Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Insomnia Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Insomnia Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Insomnia Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Takeda Pharmaceutical Company Ltd. Company Detail
Table 51. Takeda Pharmaceutical Company Ltd. Business Overview
Table 52. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product
Table 53. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 54. Takeda Pharmaceutical Company Ltd. Recent Development
Table 55. Vanda Pharmaceuticals Company Detail
Table 56. Vanda Pharmaceuticals Business Overview
Table 57. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product
Table 58. Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 59. Vanda Pharmaceuticals Recent Development
Table 60. Merck & Co., Inc. Company Detail
Table 61. Merck & Co., Inc. Business Overview
Table 62. Merck & Co., Inc. Insomnia Therapeutics Drugs Product
Table 63. Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 64. Merck & Co., Inc. Recent Development
Table 65. Pfizer Inc. Company Detail
Table 66. Pfizer Inc. Business Overview
Table 67. Pfizer Inc. Insomnia Therapeutics Drugs Product
Table 68. Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 69. Pfizer Inc. Recent Development
Table 70. Teva Pharmaceutical Industries Ltd. Company Detail
Table 71. Teva Pharmaceutical Industries Ltd. Business Overview
Table 72. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product
Table 73. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 74. Teva Pharmaceutical Industries Ltd. Recent Development
Table 75. Mylan N.V. Company Detail
Table 76. Mylan N.V. Business Overview
Table 77. Mylan N.V. Insomnia Therapeutics Drugs Product
Table 78. Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 79. Mylan N.V. Recent Development
Table 80. Sumitomo Dainippon Pharma Co., Ltd Company Detail
Table 81. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 82. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product
Table 83. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 84. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 85. Sanofi Company Detail
Table 86. Sanofi Business Overview
Table 87. Sanofi Insomnia Therapeutics Drugs Product
Table 88. Sanofi Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Paratek Pharmaceuticals Inc. Company Detail
Table 91. Paratek Pharmaceuticals Inc. Business Overview
Table 92. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product
Table 93. Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 94. Paratek Pharmaceuticals Inc. Recent Development
Table 95. Ebb Therapeutics Company Detail
Table 96. Ebb Therapeutics Business Overview
Table 97. Ebb Therapeutics Insomnia Therapeutics Drugs Product
Table 98. Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 99. Ebb Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Therapeutics Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Insomnia Therapeutics Drugs Market Share by Type: 2023 VS 2030
Figure 3. Benzodiazepines Features
Figure 4. Nonbenzodiazepines Features
Figure 5. Antidepressants Features
Figure 6. Orexin Antagonists Features
Figure 7. Melatonin Antagonists Features
Figure 8. Others Features
Figure 9. Global Insomnia Therapeutics Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Insomnia Therapeutics Drugs Market Share by Application: 2023 VS 2030
Figure 11. Prescription Case Studies
Figure 12. Over-the-Counter (OTC) Case Studies
Figure 13. Insomnia Therapeutics Drugs Report Years Considered
Figure 14. Global Insomnia Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Insomnia Therapeutics Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Insomnia Therapeutics Drugs Market Share by Region: 2023 VS 2030
Figure 17. Global Insomnia Therapeutics Drugs Market Share by Players in 2023
Figure 18. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Insomnia Therapeutics Drugs Revenue in 2023
Figure 20. North America Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Insomnia Therapeutics Drugs Market Share by Country (2019-2030)
Figure 22. United States Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Insomnia Therapeutics Drugs Market Share by Country (2019-2030)
Figure 26. Germany Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Insomnia Therapeutics Drugs Market Share by Region (2019-2030)
Figure 34. China Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Insomnia Therapeutics Drugs Market Share by Country (2019-2030)
Figure 42. Mexico Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Insomnia Therapeutics Drugs Market Share by Country (2019-2030)
Figure 46. Turkey Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 49. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 50. Merck & Co., Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 51. Pfizer Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 52. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 53. Mylan N.V. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 54. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 55. Sanofi Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 56. Paratek Pharmaceuticals Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 57. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Benzodiazepines
Table 3. Key Players of Nonbenzodiazepines
Table 4. Key Players of Antidepressants
Table 5. Key Players of Orexin Antagonists
Table 6. Key Players of Melatonin Antagonists
Table 7. Key Players of Others
Table 8. Global Insomnia Therapeutics Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Insomnia Therapeutics Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Insomnia Therapeutics Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Insomnia Therapeutics Drugs Market Share by Region (2019-2024)
Table 12. Global Insomnia Therapeutics Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Insomnia Therapeutics Drugs Market Share by Region (2025-2030)
Table 14. Insomnia Therapeutics Drugs Market Trends
Table 15. Insomnia Therapeutics Drugs Market Drivers
Table 16. Insomnia Therapeutics Drugs Market Challenges
Table 17. Insomnia Therapeutics Drugs Market Restraints
Table 18. Global Insomnia Therapeutics Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Insomnia Therapeutics Drugs Market Share by Players (2019-2024)
Table 20. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2023)
Table 21. Ranking of Global Top Insomnia Therapeutics Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Insomnia Therapeutics Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Insomnia Therapeutics Drugs Product Solution and Service
Table 25. Date of Enter into Insomnia Therapeutics Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Insomnia Therapeutics Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Insomnia Therapeutics Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Insomnia Therapeutics Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Insomnia Therapeutics Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Insomnia Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Insomnia Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Insomnia Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Insomnia Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Insomnia Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Insomnia Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Insomnia Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Insomnia Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Takeda Pharmaceutical Company Ltd. Company Detail
Table 51. Takeda Pharmaceutical Company Ltd. Business Overview
Table 52. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product
Table 53. Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 54. Takeda Pharmaceutical Company Ltd. Recent Development
Table 55. Vanda Pharmaceuticals Company Detail
Table 56. Vanda Pharmaceuticals Business Overview
Table 57. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product
Table 58. Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 59. Vanda Pharmaceuticals Recent Development
Table 60. Merck & Co., Inc. Company Detail
Table 61. Merck & Co., Inc. Business Overview
Table 62. Merck & Co., Inc. Insomnia Therapeutics Drugs Product
Table 63. Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 64. Merck & Co., Inc. Recent Development
Table 65. Pfizer Inc. Company Detail
Table 66. Pfizer Inc. Business Overview
Table 67. Pfizer Inc. Insomnia Therapeutics Drugs Product
Table 68. Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 69. Pfizer Inc. Recent Development
Table 70. Teva Pharmaceutical Industries Ltd. Company Detail
Table 71. Teva Pharmaceutical Industries Ltd. Business Overview
Table 72. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product
Table 73. Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 74. Teva Pharmaceutical Industries Ltd. Recent Development
Table 75. Mylan N.V. Company Detail
Table 76. Mylan N.V. Business Overview
Table 77. Mylan N.V. Insomnia Therapeutics Drugs Product
Table 78. Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 79. Mylan N.V. Recent Development
Table 80. Sumitomo Dainippon Pharma Co., Ltd Company Detail
Table 81. Sumitomo Dainippon Pharma Co., Ltd Business Overview
Table 82. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product
Table 83. Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 84. Sumitomo Dainippon Pharma Co., Ltd Recent Development
Table 85. Sanofi Company Detail
Table 86. Sanofi Business Overview
Table 87. Sanofi Insomnia Therapeutics Drugs Product
Table 88. Sanofi Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Paratek Pharmaceuticals Inc. Company Detail
Table 91. Paratek Pharmaceuticals Inc. Business Overview
Table 92. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product
Table 93. Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 94. Paratek Pharmaceuticals Inc. Recent Development
Table 95. Ebb Therapeutics Company Detail
Table 96. Ebb Therapeutics Business Overview
Table 97. Ebb Therapeutics Insomnia Therapeutics Drugs Product
Table 98. Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2019-2024) & (US$ Million)
Table 99. Ebb Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Insomnia Therapeutics Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Insomnia Therapeutics Drugs Market Share by Type: 2023 VS 2030
Figure 3. Benzodiazepines Features
Figure 4. Nonbenzodiazepines Features
Figure 5. Antidepressants Features
Figure 6. Orexin Antagonists Features
Figure 7. Melatonin Antagonists Features
Figure 8. Others Features
Figure 9. Global Insomnia Therapeutics Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Insomnia Therapeutics Drugs Market Share by Application: 2023 VS 2030
Figure 11. Prescription Case Studies
Figure 12. Over-the-Counter (OTC) Case Studies
Figure 13. Insomnia Therapeutics Drugs Report Years Considered
Figure 14. Global Insomnia Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Insomnia Therapeutics Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Insomnia Therapeutics Drugs Market Share by Region: 2023 VS 2030
Figure 17. Global Insomnia Therapeutics Drugs Market Share by Players in 2023
Figure 18. Global Top Insomnia Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapeutics Drugs as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Insomnia Therapeutics Drugs Revenue in 2023
Figure 20. North America Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Insomnia Therapeutics Drugs Market Share by Country (2019-2030)
Figure 22. United States Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Insomnia Therapeutics Drugs Market Share by Country (2019-2030)
Figure 26. Germany Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Insomnia Therapeutics Drugs Market Share by Region (2019-2030)
Figure 34. China Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Insomnia Therapeutics Drugs Market Share by Country (2019-2030)
Figure 42. Mexico Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Insomnia Therapeutics Drugs Market Share by Country (2019-2030)
Figure 46. Turkey Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Insomnia Therapeutics Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Takeda Pharmaceutical Company Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 49. Vanda Pharmaceuticals Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 50. Merck & Co., Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 51. Pfizer Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 52. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 53. Mylan N.V. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 54. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 55. Sanofi Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 56. Paratek Pharmaceuticals Inc. Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 57. Ebb Therapeutics Revenue Growth Rate in Insomnia Therapeutics Drugs Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232